Maven Securities LTD Novavax Inc Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $373,380 - $568,218	-2,100 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $123,783 - $263,596	1,023 Added 94.99%	2,100 $453,000
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $549,421 - $1.56 Million	-4,863 Reduced 81.87%	1,077 $195,000
Q4 2020 Feb 12, 2021	BUY	$78.74 - $139.5 $467,715 - $828,630	5,940 New	5,940 $707,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.